FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2950987628> ?p ?o ?g. }

• W2950987628 endingPage "3878" @default.
• W2950987628 startingPage "3866" @default.
• W2950987628 abstract "The optical imaging guided tumor vessels and vascular malformation visualization by using the second near infrared emission beyond 1500 nm (NIR-II) is emerged as the next generation fluorescence imaging technique for early tumor diagnosis and identification of tumor-associated vascular features. On the other hand, developing theranostic probes for NIR-II imaging guided photothermal therapy (PTT) is of great significance, which is rarely explored. Herein, a high performance theranostic nanoplatform based on the core-shell structured NaLuF4 nanorods@polydopamine (denoted as NRs@PDA) by integrating the new advanced NIR-II imaging beyond 1500 nm with PTT function was developed for tumor-associated vascular malformation visualization and imaging-guided PTT. Methods: In this work, the hydrophilic NaLuF4 NRs@PDA therapeutic probe was synthesized by using a reverse microemulsion method. The crystal phase, morphology, emission spectra and photothermal performance of the synthesized samples were systematically characterized. The NIR-II optical imaging and photothermal properties were investigated by in vitro and in vivo experiments. Results: The NaLuF4 NRs@PDA therapeutic probe possessed efficient NIR-II emission centered at 1525 nm with high quantum yield (QY), good photo-stability and high biocompatibility. In vivo NIR-IIb imaging based on the designed probe can clearly visualize the whole-body vessel and brain vessel with high spatial resolution, especially tumor-associated vessels. In addition, in vitro and in vivo experiments also demonstrated that the designed NaLuF4 NRs@PDA probe possessed efficient photothermal conversion efficiency (40.18%) for PTT ablation of tumor. Conclusion: With the excellent NIR-II imaging ability and PTT of tumor, the designed theranostic nanoplatform successfully realize the simultaneous tumor vessel diagnosis and tumor therapy, which may provide the opportunity of designing new theranostic bioprobes with combination of the NIR-II optical imaging technique and PTT function for tumor diagnosis and therapy." @default.
• W2950987628 created "2019-06-27" @default.
• W2950987628 creator A5002118929 @default.
• W2950987628 creator A5033263947 @default.
• W2950987628 creator A5044997357 @default.
• W2950987628 creator A5076041458 @default.
• W2950987628 date "2019-01-01" @default.
• W2950987628 modified "2023-10-17" @default.
• W2950987628 title "Polydopamine coated multifunctional lanthanide theranostic agent for vascular malformation and tumor vessel imaging beyond 1500 nm and imaging-guided photothermal therapy" @default.
• W2950987628 cites W1868554855 @default.
• W2950987628 cites W1969515720 @default.
• W2950987628 cites W1977791081 @default.
• W2950987628 cites W1978762833 @default.
• W2950987628 cites W1980107343 @default.
• W2950987628 cites W1984705626 @default.
• W2950987628 cites W1993578007 @default.
• W2950987628 cites W1994023367 @default.
• W2950987628 cites W1995651581 @default.
• W2950987628 cites W1996258924 @default.
• W2950987628 cites W2023812730 @default.
• W2950987628 cites W2030054103 @default.
• W2950987628 cites W2033156964 @default.
• W2950987628 cites W2056069790 @default.
• W2950987628 cites W2073948019 @default.
• W2950987628 cites W2079625753 @default.
• W2950987628 cites W2096786458 @default.
• W2950987628 cites W2100635475 @default.
• W2950987628 cites W2100892270 @default.
• W2950987628 cites W2128816083 @default.
• W2950987628 cites W2148250546 @default.
• W2950987628 cites W2149181197 @default.
• W2950987628 cites W2154538395 @default.
• W2950987628 cites W2217123187 @default.
• W2950987628 cites W2258090705 @default.
• W2950987628 cites W2261575366 @default.
• W2950987628 cites W2271765889 @default.
• W2950987628 cites W2315759364 @default.
• W2950987628 cites W2320589001 @default.
• W2950987628 cites W2324564321 @default.
• W2950987628 cites W2326443463 @default.
• W2950987628 cites W2333685381 @default.
• W2950987628 cites W2334075244 @default.
• W2950987628 cites W2516286436 @default.
• W2950987628 cites W2590750118 @default.
• W2950987628 cites W2614165899 @default.
• W2950987628 cites W2616212523 @default.
• W2950987628 cites W2738223703 @default.
• W2950987628 cites W2739021049 @default.
• W2950987628 cites W2760538791 @default.
• W2950987628 cites W2767204017 @default.
• W2950987628 cites W2796044033 @default.
• W2950987628 cites W2838691592 @default.
• W2950987628 cites W2886949120 @default.
• W2950987628 cites W328805369 @default.
• W2950987628 cites W4232364319 @default.
• W2950987628 cites W4237878273 @default.
• W2950987628 cites W766260328 @default.
• W2950987628 doi "https://doi.org/10.7150/thno.31864" @default.
• W2950987628 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6587345" @default.
• W2950987628 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31281519" @default.
• W2950987628 hasPublicationYear "2019" @default.
• W2950987628 type Work @default.
• W2950987628 sameAs 2950987628 @default.
• W2950987628 citedByCount "52" @default.
• W2950987628 countsByYear W29509876282019 @default.
• W2950987628 countsByYear W29509876282020 @default.
• W2950987628 countsByYear W29509876282021 @default.
• W2950987628 countsByYear W29509876282022 @default.
• W2950987628 countsByYear W29509876282023 @default.
• W2950987628 crossrefType "journal-article" @default.
• W2950987628 hasAuthorship W2950987628A5002118929 @default.
• W2950987628 hasAuthorship W2950987628A5033263947 @default.
• W2950987628 hasAuthorship W2950987628A5044997357 @default.
• W2950987628 hasAuthorship W2950987628A5076041458 @default.
• W2950987628 hasBestOaLocation W29509876281 @default.
• W2950987628 hasConcept C120665830 @default.
• W2950987628 hasConcept C121332964 @default.
• W2950987628 hasConcept C126201875 @default.
• W2950987628 hasConcept C136229726 @default.
• W2950987628 hasConcept C150903083 @default.
• W2950987628 hasConcept C171250308 @default.
• W2950987628 hasConcept C182606246 @default.
• W2950987628 hasConcept C191897082 @default.
• W2950987628 hasConcept C192562407 @default.
• W2950987628 hasConcept C207001950 @default.
• W2950987628 hasConcept C2777230088 @default.
• W2950987628 hasConcept C29331040 @default.
• W2950987628 hasConcept C57477423 @default.
• W2950987628 hasConcept C71924100 @default.
• W2950987628 hasConcept C86803240 @default.
• W2950987628 hasConcept C91881484 @default.
• W2950987628 hasConceptScore W2950987628C120665830 @default.
• W2950987628 hasConceptScore W2950987628C121332964 @default.
• W2950987628 hasConceptScore W2950987628C126201875 @default.
• W2950987628 hasConceptScore W2950987628C136229726 @default.
• W2950987628 hasConceptScore W2950987628C150903083 @default.
• W2950987628 hasConceptScore W2950987628C171250308 @default.
• W2950987628 hasConceptScore W2950987628C182606246 @default.

• next